Using decoy peptides to treat autoimmune-related long QT syndrome
Rescue of Autoimmune-Associated Long QT Syndrome by Decoy Peptides
This study is looking at how certain immune responses can cause long QT syndrome, a heart condition that can lead to dangerous heart rhythms, and it aims to help patients with autoimmune diseases by using special treatments to block harmful antibodies and improve heart function.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Narrows Institute for Biomedical Res INC NIH-funded |
| Lab location | 1 site (Brooklyn, United States) |
| Project ID | NIH-10895314 on NIH RePORTER |
What this research studies
This research investigates how autoimmune responses can lead to long QT syndrome, a serious heart condition that increases the risk of dangerous arrhythmias. The study focuses on specific autoantibodies that interfere with heart cell function, particularly affecting ion channels that regulate heart rhythms. By developing decoy peptides, the researchers aim to block these harmful autoantibodies and restore normal heart function. Patients with autoimmune diseases or those with specific autoantibodies may be able to participate in this innovative approach.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with autoimmune diseases who also exhibit symptoms of long QT syndrome.
Not a fit: Patients without autoimmune conditions or those not exhibiting long QT syndrome may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new treatment option for patients suffering from long QT syndrome caused by autoimmune factors.
How similar studies have performed: While the approach of using decoy peptides is innovative, similar strategies targeting autoimmune mechanisms in cardiac conditions have shown promise in preliminary studies.
Where this research is happening
Brooklyn, United States
- Narrows Institute for Biomedical Res INC — Brooklyn, United States (Active)
Researchers
- Principal investigator: Boutjdir, Mohamed — Narrows Institute for Biomedical Res INC
- Study coordinator: Boutjdir, Mohamed
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.